Published in
American Society for Clinical Investigation, Journal of Clinical Investigation
DOI: 10.1172/jci124920
American Society for Clinical Investigation, Journal of Clinical Investigation, 2(128), p. 789-804
DOI: 10.1172/jci94516
Links
- ORCID
- ORCID
- ORCID
- ORCID
- ORCID
- American Society for Clinical Investigation | PDF
- American Society for Clinical Investigation | PDF
- [dspace.mit.edu] | PDF
- [europepmc.org] | PDF
Tools
JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
Journal article published in 2018 by
Anna Sophia McKenney,
Allison N. Lau 
,
Amritha Varshini Hanasoge Somasundara,
McKenney As,
Barbara Spitzer,
Andrew M. Intlekofer ,
Lau An,
Mya Steadman,
Jihae Ahn,
Katharine Yen,
Franck T. Rapaport ,
Kaitlyn Shank,
Somasundara Avh,
Minal A. Patel,
Julie Teruya-Feldstein
and other authors.
,
Amritha Varshini Hanasoge Somasundara,
McKenney As,
Barbara Spitzer,
Andrew M. Intlekofer ,
Lau An,
Mya Steadman,
Jihae Ahn,
Katharine Yen,
Franck T. Rapaport ,
Kaitlyn Shank,
Somasundara Avh,
Minal A. Patel,
Julie Teruya-Feldstein
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 